PortfoliosLab logoPortfoliosLab logo
VMD vs. AGL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VMD vs. AGL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Viemed Healthcare Inc (VMD) and agilon health, inc. (AGL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VMD achieves a 57.07% return, which is significantly lower than AGL's 432.07% return.


VMD

1D
-0.77%
1M
-2.91%
6M
52.15%
YTD
57.07%
1Y
96.80%
3Y*
9.95%
5Y*
10.89%
10Y*
ALL TIME*
25.12%

AGL

1D
-5.31%
1M
-17.48%
6M
340.33%
YTD
432.07%
1Y
115.55%
3Y*
-41.50%
5Y*
-36.95%
10Y*
ALL TIME*
-32.02%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$31.50M$33.68M$35.49M
$3.09M$3.53M$3.18M

VMD vs. AGL - Yearly Performance Comparison


2026 (YTD)20252024202320222021
VMD
Viemed Healthcare Inc
57.07%-7.36%2.17%3.84%44.83%-46.46%
AGL
agilon health, inc.
432.07%-63.75%-84.86%-22.24%-40.22%-4.42%

Correlation

The correlation between VMD and AGL is 0.18, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.18

Correlation (3Y)
Balances recent behavior with more history.

0.18

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.16

Correlation (All Time)
Calculated using the full available price history since Apr 15, 2021

0.15

Fundamentals

Market Cap

VMD:

$447.39M

AGL:

$1.53B

EPS

VMD:

$0.37

AGL:

-$22.49

PS Ratio

VMD:

1.64

AGL:

0.26

PB Ratio

VMD:

3.28

AGL:

8.41

Total Revenue (TTM)

VMD:

$286.57M

AGL:

$5.82B

Gross Profit (TTM)

VMD:

$163.52M

AGL:

-$225.14M

EBITDA (TTM)

VMD:

$46.09M

AGL:

-$340.64M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VMD vs. AGL — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

VMD
VMD Risk / Return Rank: 9494
Overall Rank
VMD Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
VMD Sortino Ratio Rank: 9191
Sortino Ratio Rank
VMD Omega Ratio Rank: 9292
Omega Ratio Rank
VMD Calmar Ratio Rank: 9696
Calmar Ratio Rank
VMD Martin Ratio Rank: 9696
Martin Ratio Rank

AGL
AGL Risk / Return Rank: 7474
Overall Rank
AGL Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
AGL Sortino Ratio Rank: 8484
Sortino Ratio Rank
AGL Omega Ratio Rank: 8585
Omega Ratio Rank
AGL Calmar Ratio Rank: 7171
Calmar Ratio Rank
AGL Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

VMD vs. AGL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Viemed Healthcare Inc (VMD) and agilon health, inc. (AGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VMDAGLDifference
Sharpe ratioReturn per unit of total volatility

+1.81

Sortino ratioReturn per unit of downside risk

+0.55

Omega ratioGain probability vs. loss probability

1.40

1.31

+0.09

Calmar ratioReturn relative to maximum drawdown

5.81

1.28

+4.53

Martin ratioReturn relative to average drawdown

14.86

2.15

+12.71

VMD vs. AGL - Sharpe Ratio Comparison

The current VMD Sharpe Ratio is 2.41, which is higher than the AGL Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of VMD and AGL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VMD vs. AGL - Drawdown Comparison

The maximum VMD drawdown since its inception was -69.35%, smaller than the maximum AGL drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for VMD and AGL.


Loading charts...

Drawdown Indicators


VMDAGLDifference

Max Drawdown

Largest peak-to-trough decline

-69.35%

-99.27%

+29.92%

Max Drawdown (1Y)

Largest decline over 1 year

-15.86%

-82.57%

+66.71%

Max Drawdown (3Y)

Largest decline over 3 years

-40.64%

-98.43%

+57.79%

Max Drawdown (5Y)

Largest decline over 5 years

-49.62%

-99.18%

+49.56%

Current Drawdown

Current decline from peak

-5.35%

-91.53%

+86.18%

Average Drawdown

Average peak-to-trough decline

-29.04%

-68.39%

+39.35%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.19%

48.89%

-42.70%

Volatility

VMD vs. AGL - Volatility Comparison

The current volatility for Viemed Healthcare Inc (VMD) is 7.08%, while agilon health, inc. (AGL) has a volatility of 25.02%. This indicates that VMD experiences smaller price fluctuations and is considered to be less risky than AGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VMDAGLDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.08%

25.02%

-17.94%

Volatility (6M)

Calculated over the trailing 6-month period

29.76%

126.81%

-97.05%

Volatility (1Y)

Calculated over the trailing 1-year period

38.23%

175.68%

-137.45%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

40.92%

103.70%

-62.78%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

57.44%

101.49%

-44.05%

Dividends

VMD vs. AGL - Dividend Comparison

Neither VMD nor AGL has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

VMD vs. AGL - Financials Comparison

This section allows you to compare key financial metrics between Viemed Healthcare Inc and agilon health, inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

VMD vs. AGL - Profitability Comparison

The chart below illustrates the profitability comparison between Viemed Healthcare Inc and agilon health, inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

VMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Viemed Healthcare Inc reported a gross profit of 42.83M and revenue of 75.41M. Therefore, the gross margin over that period was 56.8%.

AGL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, agilon health, inc. reported a gross profit of 0.00 and revenue of 1.42B. Therefore, the gross margin over that period was 0.0%.

VMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Viemed Healthcare Inc reported an operating income of 4.30M and revenue of 75.41M, resulting in an operating margin of 5.7%.

AGL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, agilon health, inc. reported an operating income of 4.00M and revenue of 1.42B, resulting in an operating margin of 0.3%.

VMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Viemed Healthcare Inc reported a net income of 2.58M and revenue of 75.41M, resulting in a net margin of 3.4%.

AGL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, agilon health, inc. reported a net income of 29.97M and revenue of 1.42B, resulting in a net margin of 2.1%.


Frequently Asked Questions


VMD and AGL have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AGL has higher volatility (25.02%) compared to VMD (7.08%). In terms of maximum drawdown, VMD dropped -69.35% vs AGL's -99.27%.

VMD currently has the higher Sharpe Ratio (2.41 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VMD and AGL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer